How do you bridge from warfarin (Coumadin) to Xarelto (Rivaroxaban) preoperatively?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bridging from Warfarin to Xarelto Preoperatively

You do not "bridge" from warfarin to Xarelto (rivaroxaban) preoperatively—instead, you stop warfarin 5 days before surgery, and then start Xarelto postoperatively once hemostasis is achieved. The term "bridging" specifically refers to using short-acting parenteral anticoagulants (like LMWH or heparin) to cover the period when warfarin is stopped, not transitioning between two oral anticoagulants. 1, 2

Preoperative Warfarin Management

Stopping Warfarin Before Surgery

  • Stop warfarin 5-6 days before major surgery to allow the INR to normalize, based on warfarin's 36-42 hour half-life requiring approximately 5 half-lives for adequate clearance. 3

  • Check INR the day before surgery and proceed if INR ≤1.5 for most procedures. 1, 4

  • If INR remains >1.5 but ≤1.8 the day before surgery, consider low-dose oral vitamin K (1-2.5 mg) to expedite normalization. 1

Determining Need for Heparin Bridging

Bridging with LMWH or heparin is only indicated for high thromboembolic risk patients, not as a routine transition to Xarelto. 3, 1

High-risk patients requiring bridging include: 1

  • Recent VTE within 3 months
  • Active cancer with VTE
  • Mechanical heart valves
  • Atrial fibrillation with high CHADS₂ score
  • Antiphospholipid syndrome with recurrent thrombosis

Low-risk patients do NOT require bridging: 1

  • Atrial fibrillation with low CHADS₂ score
  • VTE more than 3 months ago
  • No other major risk factors

If Bridging is Required (High-Risk Patients Only)

  • Start therapeutic LMWH when INR falls below 2.0, typically 3 days before surgery (e.g., enoxaparin 1 mg/kg twice daily or 1.5 mg/kg once daily). 1

  • Give the last preoperative LMWH dose 24 hours before surgery at half the total daily dose. 1

Postoperative Management

Resuming Anticoagulation

  • Resume warfarin 12-24 hours after surgery when adequate hemostasis is established. 3, 1

  • If bridging was used, continue therapeutic LMWH until INR reaches ≥2.0 in the therapeutic range. 1

  • For high bleeding risk procedures, delay therapeutic LMWH for 48-72 hours, but prophylactic LMWH may be started 12 hours postoperatively. 1

Transitioning to Xarelto Postoperatively

When switching from warfarin to Xarelto after surgery: 2

  • Discontinue warfarin and start Xarelto as soon as INR is below 3.0 in adults (below 2.5 in pediatric patients) to avoid periods of inadequate anticoagulation. 2

  • This transition typically occurs several days postoperatively once warfarin has re-established therapeutic anticoagulation and the decision is made to switch to a DOAC.

  • Do not start Xarelto immediately postoperatively—wait until hemostasis is secure and you would normally restart anticoagulation (12-24 hours minimum, longer for high bleeding risk). 2

Critical Pitfalls to Avoid

  • Do not confuse "bridging" with "switching": Bridging uses parenteral anticoagulants temporarily; switching means changing from one oral agent to another. 1, 2

  • Do not start Xarelto preoperatively while stopping warfarin—this creates overlapping anticoagulation and increases bleeding risk without established benefit. 2

  • Do not bridge low-risk patients—this increases bleeding complications without reducing thrombotic events. 1

  • For minor procedures (dental, dermatologic, cataract surgery), continuing warfarin may be safer than stopping it, eliminating the need for any transition. 3, 1

References

Guideline

Warfarin Bridging Protocol for Surgery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

An update of consensus guidelines for warfarin reversal.

The Medical journal of Australia, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.